Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025)

Eton Pharmaceuticals has disclosed Free Cash Flow across 8 years of filings, most recently posting -$11.6 million for Q4 2025.

• In Q4 2025, Free Cash Flow fell 1392.92% year-over-year to -$11.6 million; the TTM figure through Dec 2025 stood at $10.2 million (up 980.7% YoY), while the FY2025 annual figure was $10.2 million, up 980.7% from the prior year.
• Free Cash Flow came in at -$11.6 million for Q4 2025 at Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.6 million in Q4 2025.
• Average Free Cash Flow over 5 years is $900250.0, with a median of $1.0 million recorded in 2022.
• Year-over-year, Free Cash Flow soared 763.96% in 2022 and plunged 1392.92% in 2025.
• Over 5 years, Free Cash Flow stood at -$5.1 million in 2021, then jumped by 155.22% to $2.8 million in 2022, then slumped by 86.32% to $387000.0 in 2023, then tumbled by 300.78% to -$777000.0 in 2024, then sank by 1392.92% to -$11.6 million in 2025.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$11.6 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.